USPH - U.S. Physical Therapy, Inc.
NEXT EARNINGS:
Feb 25, 2026
(today)
EPS Est: $0.67
|
Rev Est: $200.1M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$98.00
DETAILS
HIGH:
$98.00
LOW:
$98.00
MEDIAN:
$98.00
CONSENSUS:
$98.00
UPSIDE:
18.24%
Market Cap:
1.26B
Volume:
128,320
Avg Volume:
202,188
52 Week Range:
62.77-93.5
Sector:
Healthcare
Industry:
Medical - Care Facilities
Beta:
1.30
Last Dividend:
$1.80
Exchange:
NYSE
Country:
US
Employees:
4,034
IPO Date:
1992-05-29
EPS (TTM):
1.84
P/E Ratio:
50.50
Revenue (TTM):
671.35M
Total Assets:
1.17B
Total Debt:
295.23M
Cash & Equiv:
41.36M
Rev Growth (5Y):
6.8%
EPS Growth (5Y):
-16.3%
FCF Growth (5Y):
4.7%
ROCE:
6.5%
Debt/Equity:
0.60
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-05 | $0.66 | $0.67 | -1.5% | $164.0M | $200.1M | -18.0% |
| 2025-08-06 | $0.81 | $0.71 | +14.1% | $164.2M | $189.9M | -13.5% |
| 2025-05-07 | $0.48 | $0.46 | +4.3% | $152.5M | $188.2M | -18.9% |
| 2025-02-26 | $0.65 | $0.69 | -5.8% | $180.4M | $173.1M | +4.2% |
| 2024-11-05 | $0.69 | $0.68 | +1.5% | $168.0M | $171.9M | -2.2% |
| 2024-08-13 | $0.73 | $0.81 | -9.9% | $167.2M | $162.3M | +3.0% |
| 2024-05-07 | $0.51 | $0.56 | -8.9% | $155.7M | $155.7M | 0.0% |
| 2024-02-28 | $0.59 | $0.57 | +3.5% | $154.8M | $154.8M | 0.0% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 671.35M | 604.80M | 553.14M | 495.02M | 422.97M | 481.97M | 453.91M | 414.05M | 356.55M | 331.30M | 305.07M | 264.06M |
| Net Income | 26.46M | 14.67M | 28.27M | 27.82M | 30.56M | 28.15M | 10.10M | 22.26M | 20.55M | 22.28M | 19.77M | 12.72M |
| EPS | 1.84 | 1.28 | 3.34 | 4.49 | 4.09 | 4.49 | 0.80 | 1.76 | 1.64 | 1.77 | 1.62 | 1.05 |
| Total Assets | 1.17B | 997.24M | 858.15M | 749.43M | 594.36M | 560.85M | 443.17M | 418.98M | 351.23M | 279.91M | 244.55M | 224.13M |
| Total Debt | 295.23M | 258.59M | 295.34M | 223.08M | 110.99M | 137.83M | 39.84M | 60.77M | 51.82M | 49.11M | 35.62M | 41.48M |
| Cash & Equivalents | 41.36M | 152.82M | 31.59M | 28.57M | 32.92M | 23.55M | 23.37M | 21.93M | 20.05M | 15.78M | 14.27M | 12.90M |
| Operating Cash Flow | 74.94M | 81.98M | 58.54M | 76.41M | 100.00M | 62.45M | 73.00M | 56.53M | 51.05M | 41.24M | 45.19M | 44.80M |
| Free Cash Flow | 65.75M | 72.68M | 50.29M | 68.20M | 92.36M | 52.26M | 65.81M | 49.43M | 42.79M | 34.98M | 40.03M | 40.16M |
| FCF per Share | 4.36 | 5.12 | 3.87 | 5.29 | 7.20 | 4.10 | 5.20 | 3.93 | 3.42 | 2.82 | 3.28 | 3.33 |
| Book Value | 488.93M | 476.19M | 315.79M | 295.61M | 276.16M | 240.26M | 215.94M | 204.87M | 187.55M | 162.78M | 146.28M | 128.29M |
| Cash & ST Investments | 41.36M | 152.82M | 31.59M | 28.57M | 32.92M | 23.55M | 23.37M | 21.93M | 20.05M | 15.78M | 14.27M | 12.90M |
| ROC Equity | 0.05 | 0.03 | 0.09 | 0.09 | 0.11 | 0.12 | 0.05 | 0.11 | 0.11 | 0.14 | 0.14 | 0.10 |